Australian regulator promises to cut drug evaluation times by "a year"
This article was originally published in Scrip
Executive Summary
Plans by the Australian drug regulator, the Therapeutic Goods Administration, to cut evaluation times for prescription drug dossiers by a year have been welcomed by Medicines Australia, the national pharmaceutical industry association.